Results 221 to 230 of about 118,303 (321)

Drug Use After Emergency Department‐Initiated Injectable Buprenorphine: A Secondary Analysis of the ED‐INNOVATION Ancillary Safety and Feasibility Trial

Academic Emergency Medicine, Volume 33, Issue 3, March 2026.
ABSTRACT Study Objective To characterize opioid and nonopioid drug use in the week following emergency department (ED)‐initiated extended‐release buprenorphine (XR‐BUP) treatment using both self‐reported data and urine drug screens (UDS). Methods This study uses data collected during a nonrandomized clinical trial of patients with untreated opioid use ...
Ethan Cowan, Gail D'Onofrio, Jeanmarie Perrone, Erik Anderson, James Dziura, Kathryn Hawk, Andrew Herring, Ryan McCormack, Manali Phadke, Elizabeth A. Samuels, David A. Fiellin   +10 more
wiley   +1 more source

A Cohort Comparison of Buprenorphine versus Methadone Treatment for Neonatal Abstinence Syndrome.

Jornal de Pediatria, 2016
E. Hall, B. Isemann, Scott L. Wexelblatt, J. Meinzen-Derr, Jason R. Wiles, S. Harvey, H. Akinbi   +6 more
semanticscholar   +1 more source

Acceptability of and Implementation Supports for Video Directly Observed Treatment to Enhance Methadone Dosing Flexibility in a Multisite Opioid Treatment Program: Qualitative Rapid Needs Assessment Study. [PDF]

JMIR Form Res
Tsui JI, Austin EJ, Dunn JA, Gojic AJ, Bhatraju EP, Darnton J, Grekin P, Soth S, Woolworth S, Williams EC, Hallgren KA.   +10 more
europepmc   +1 more source

Participant ascertainment is differentially related to phenotypic characteristics and alcohol‐related genetic liability in a sample with severe alcohol use disorder

Alcohol, Clinical and Experimental Research, Volume 50, Issue 3, March 2026.
Using multiple recruitment modalities for studies of individuals with alcohol use disorder can expand the phenotypic and genetic heterogeneity of a sample, potentially making it more representative. Abstract Background Alcohol use disorder (AUD) is a common substance use disorder associated with a range of sociodemographic, behavioral, and genetic ...
Alexis C. Edwards, Kristin Passero, Michelle Eglovitch, Kathryn Polak, Anna Beth Parlier‐Ahmad, Enkelejda Ngjelina, Mallory Stephenson, Severine Lannoy, Dace Svikis, Kenneth Kendler   +9 more
wiley   +1 more source

Trends in Methadone Distribution for Pain Treatment, Methadone Diversion, and Overdose Deaths - United States, 2002-2014.

MMWR. Morbidity and mortality weekly report, 2016
Christopher M. Jones, G. Baldwin, Teresa Manocchio, Jessica O White, K. Mack   +4 more
semanticscholar   +1 more source

Psilocybin and Ibogaine in Cocaine‐Seeking: Extinction Enhancement Without Relapse Prevention

Addiction Biology, Volume 31, Issue 3, March 2026.
Using a preclinical model of cocaine self‐administration, we examined the effects of psilocybin and ibogaine on extinction learning and relapse‐like behaviour. Both compounds, administered during the extinction phase, reduced cocaine seeking, indicating facilitation of extinction learning. However, neither treatment prevented cue‐induced reinstatement.
Isis Rita Anzel Koutrouli, Vojtěch Brejtr, Marek Schwendt, Kacper Witek, Chrysostomos Charalambous, Kristýna Aleksič, Nina Miniariková, Eva Lhotková, Martin Toman, Marek Nikolič, Radek Jurok, Petra Cihlářová, Vladimír Mazoch, Pavel Ryšánek, Martin Kuchař, Klára Šíchová, Tomáš Páleníček   +16 more
wiley   +1 more source

"With this you're not chained down to something": contrasting experiences of opioid agonist treatment and safer supply program participation among people receiving prescribed safer supply. [PDF]

Harm Reduct J
Michaud L, Guta A, Perri M, Schaff A, Boyle M, King K, Strike C, Kolla G.   +7 more
europepmc   +1 more source

Managing the Complex Intersection Between Substance Use Disorders and Infectious Diseases

JACCP: JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY, Volume 9, Issue 3, March 2026.
Karissa Chow, Amanda Binkley, Jessica Meisner, Samantha Huo, Matthew Hinton   +4 more
wiley   +1 more source

The Buprenorphine Paradox: How Buprenorphine Triggers and Resolves Opioid Withdrawal

Addiction Biology, Volume 31, Issue 3, March 2026.
Buprenorphine can either precipitate or relieve opioid withdrawal depending on the timing of administration relative to full opioid agonist exposure. The article proposes that buprenorphine promotes mu‐opioid receptor (MOR) externalization and resensitization, creating a temporary signaling gap that explains precipitated withdrawal when full agonists ...
Mehdi Haghdoost, Jennifer LaBranche, Matthew Roberts, Victor W. Li, Jane J. Kim, James S. H. Wong, Pouya Azar   +6 more
wiley   +1 more source

Feasibility and Preliminary Efficacy of Empowered Relief in Patients With Chronic Pain Taking Methadone or Buprenorphine: Single-Arm National Pilot Study. [PDF]

JMIR Form Res
You D, Edwards KA, Ziadni MS, Kim S, Klein MR, Cox R, Raney E, Kuchera J, Darnall BD.   +8 more
europepmc   +1 more source